NGS testing with Foundation Medicine Inc assays does not cover the whole exome/genome, so while NTRK1/2/3 are interrogated, including all exons and specific introns, the description of the genomic characteristics of NTRK fusion-positive cancers cannot be considered exhaustive. Here, NTRK1 is linked to cancer.